Publications
Found 1 results
Filters: Author is W.-W. Xu [Clear All Filters]
“Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China”, vol. 11, pp. 4330-4341, 2012.
, Bestor TH (2000). The DNA methyltransferases of mammals. Hum. Mol. Genet. 9: 2395-2402.
http://dx.doi.org/10.1093/hmg/9.16.2395
PMid:11005794
Brenner C, Deplus R, Didelot C, Loriot A, et al. (2005). Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 24: 336-346.
http://dx.doi.org/10.1038/sj.emboj.7600509
PMid:15616584 PMCid:545804
Cai FF, Kohler C, Zhang B, Wang MH, et al. (2011). Epigenetic therapy for breast cancer. Int. J. Mol. Sci. 12: 4465-4487.
http://dx.doi.org/10.3390/ijms12074465
PMid:21845090 PMCid:3155363
Cebrian A, Pharoah PD, Ahmed S, Ropero S, et al. (2006). Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis 27: 1661-1669.
http://dx.doi.org/10.1093/carcin/bgi375
PMid:16501248
Deplus R, Brenner C, Burgers WA, Putmans P, et al. (2002). Dnmt3L is a transcriptional repressor that recruits histone deacetylase. Nucleic Acids Res. 30: 3831-3838.
http://dx.doi.org/10.1093/nar/gkf509
PMid:12202768 PMCid:137431
Easwaran HP, Schermelleh L, Leonhardt H and Cardoso MC (2004). Replication-independent chromatin loading of Dnmt1 during G2 and M phases. EMBO Rep. 5: 1181-1186.
http://dx.doi.org/10.1038/sj.embor.7400295
PMid:15550930 PMCid:1299190
Egger G, Liang G, Aparicio A and Jones PA (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463.
http://dx.doi.org/10.1038/nature02625
PMid:15164071
Ehrlich M (2002). DNA methylation in cancer: too much, but also too little. Oncogene 21: 5400-5413.
http://dx.doi.org/10.1038/sj.onc.1205651
PMid:12154403
Esteller M, Silva JM, Dominguez G, Bonilla F, et al. (2000). Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 92: 564-569.
http://dx.doi.org/10.1093/jnci/92.7.564
PMid:10749912
Fan H, Liu D, Qiu X, Qiao F, et al. (2010). A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma. BMC Med. 8: 12.
http://dx.doi.org/10.1186/1741-7015-8-12
PMid:20128888 PMCid:2829483
Franke A, McGovern DP, Barrett JC, Wang K, et al. (2010). Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42: 1118-1125.
http://dx.doi.org/10.1038/ng.717
PMid:21102463 PMCid:3299551
Fuks F, Burgers WA, Godin N, Kasai M, et al. (2001). Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J. 20: 2536-2544.
http://dx.doi.org/10.1093/emboj/20.10.2536
PMid:11350943 PMCid:125250
Goll MG, Kirpekar F, Maggert KA, Yoder JA, et al. (2006). Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 311: 395-398.
http://dx.doi.org/10.1126/science.1120976
PMid:16424344
Gudbjartsson DF, Walters GB, Thorleifsson G, Stefansson H, et al. (2008). Many sequence variants affecting diversity of adult human height. Nat. Genet. 40: 609-615.
http://dx.doi.org/10.1038/ng.122
PMid:18391951
Haggarty P, Hoad G, Harris SE, Starr JM, et al. (2010). Human intelligence and polymorphisms in the DNA methyltransferase genes involved in epigenetic marking. PLoS One 5: e11329.
http://dx.doi.org/10.1371/journal.pone.0011329
PMid:20593030 PMCid:2892514
Herman JG and Baylin SB (2003). Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349: 2042-2054.
http://dx.doi.org/10.1056/NEJMra023075
PMid:14627790
Hu J, Fan H, Liu D, Zhang S, et al. (2010). DNMT3B promoter polymorphism and risk of gastric cancer. Dig. Dis. Sci. 55: 1011-1016.
http://dx.doi.org/10.1007/s10620-009-0831-3
PMid:19517237
Jemal A, Bray F, Center MM, Ferlay J, et al. (2011). Global cancer statistics. CA Cancer J. Clin. 61: 69-90.
http://dx.doi.org/10.3322/caac.20107
PMid:21296855
Jones PA and Baylin SB (2002). The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3: 415-428.
PMid:12042769
Kanai Y, Ushijima S, Nakanishi Y, Sakamoto M, et al. (2003). Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. Cancer Lett. 192: 75-82.
http://dx.doi.org/10.1016/S0304-3835(02)00689-4
Kang ES, Park CW and Chung JH (2001). Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1. Biochem. Biophys. Res. Commun. 289: 862-868.
http://dx.doi.org/10.1006/bbrc.2001.6057
PMid:11735126
Kelemen LE, Sellers TA, Schildkraut JM, Cunningham JM, et al. (2008). Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res. 68: 2498-2506.
http://dx.doi.org/10.1158/0008-5472.CAN-07-5165
PMid:18381459 PMCid:2786310
Kim GD, Ni J, Kelesoglu N, Roberts RJ, et al. (2002). Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 21: 4183-4195.
http://dx.doi.org/10.1093/emboj/cdf401
PMid:12145218 PMCid:126147
Lee SJ, Jeon HS, Jang JS, Park SH, et al. (2005). DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 26: 403-409.
http://dx.doi.org/10.1093/carcin/bgh307
PMid:15528220
Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, et al. (2003). Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 13: 1192-1200.
http://dx.doi.org/10.1016/S0960-9822(03)00432-9